EPA-话题@MedSci

#EPA#

1120篇内容 | 2777人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1427134, encodeId=cfe8142e134ed, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差, objectType=article, longId=140112, objectId=29041401126d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29041401126d, replyNumber=0, likeNumber=105, createdTime=2018-06-07, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29041401126d, moduleTitle=J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29041401126d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427133, encodeId=6abb142e133d4, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Viral Hepat：埃及丙型肝炎患者采用DAA治疗后，肝癌复发率增加, objectType=article, longId=140111, objectId=33241401119a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33241401119a, replyNumber=0, likeNumber=82, createdTime=2018-06-07, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33241401119a, moduleTitle=J Viral Hepat：埃及丙型肝炎患者采用DAA治疗后，肝癌复发率增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33241401119a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427132, encodeId=fe31142e13247, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatol Res：在日本CHB患者中，早期从恩替卡韦治疗转换到聚乙二醇干扰素的序贯治疗，结果并不令人满意, objectType=article, longId=140003, objectId=fbd714000360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd714000360, replyNumber=0, likeNumber=70, createdTime=2018-06-06, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd714000360, moduleTitle=Hepatol Res：在日本CHB患者中，早期从恩替卡韦治疗转换到聚乙二醇干扰素的序贯治疗，结果并不令人满意, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbd714000360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427131, encodeId=cd2f142e13153, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：慢加急性肝功能衰竭(ACLF)和失代偿性肝硬化(INR)患者凝血功能衰竭, objectType=article, longId=140002, objectId=ed09140002c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed09140002c7, replyNumber=0, likeNumber=69, createdTime=2018-06-06, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed09140002c7, moduleTitle=Hepatology：慢加急性肝功能衰竭(ACLF)和失代偿性肝硬化(INR)患者凝血功能衰竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed09140002c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427130, encodeId=5b41142e1304f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响, objectType=article, longId=139533, objectId=a57d139533c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a57d139533c1, replyNumber=0, likeNumber=71, createdTime=2018-06-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a57d139533c1, moduleTitle=Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a57d139533c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427129, encodeId=8869142e12998, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatol Res：肝硬化患者脾脏组织的病理结果, objectType=article, longId=139532, objectId=79f613953247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f613953247, replyNumber=0, likeNumber=72, createdTime=2018-06-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f613953247, moduleTitle=Hepatol Res：肝硬化患者脾脏组织的病理结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79f613953247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427128, encodeId=e0ac142e12811, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatol Res：在韩国接受恩替卡韦/替诺福韦治疗的慢性乙型肝炎患者的肝细胞癌风险, objectType=article, longId=139531, objectId=82bb139531a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82bb139531a9, replyNumber=0, likeNumber=65, createdTime=2018-06-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82bb139531a9, moduleTitle=Hepatol Res：在韩国接受恩替卡韦/替诺福韦治疗的慢性乙型肝炎患者的肝细胞癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82bb139531a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427127, encodeId=e04a142e12771, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：患有非酒精性肝病的糖尿病患者，其心血管疾病的风险增加, objectType=article, longId=139437, objectId=a60913943e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a60913943e2a, replyNumber=0, likeNumber=74, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a60913943e2a, moduleTitle=Eur J Gastroenterol Hepatol：患有非酒精性肝病的糖尿病患者，其心血管疾病的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a60913943e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427126, encodeId=12b2142e126d4, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：HA和M30，联合或单独使用，可能能够预测非酒精性肝病患者的显著肝纤维化, objectType=article, longId=139435, objectId=7e51139435a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e51139435a3, replyNumber=0, likeNumber=61, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e51139435a3, moduleTitle=Eur J Gastroenterol Hepatol：HA和M30，联合或单独使用，可能能够预测非酒精性肝病患者的显著肝纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e51139435a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427125, encodeId=ae35142e12539, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：一种新的非侵入性测试用于非酒精性脂肪性肝炎的诊断, objectType=article, longId=139432, objectId=605f139432a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=605f139432a5, replyNumber=0, likeNumber=76, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=605f139432a5, moduleTitle=Eur J Gastroenterol Hepatol：一种新的非侵入性测试用于非酒精性脂肪性肝炎的诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=605f139432a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427124, encodeId=b2bd142e12431, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：先前的乙型肝炎病毒感染可能加重了原发性胆汁性胆管炎的严重程度，可能导致较差的结果, objectType=article, longId=139424, objectId=81ce13942435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81ce13942435, replyNumber=0, likeNumber=76, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81ce13942435, moduleTitle=Eur J Gastroenterol Hepatol：先前的乙型肝炎病毒感染可能加重了原发性胆汁性胆管炎的严重程度，可能导致较差的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81ce13942435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427123, encodeId=1393142e123e9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterlogy and Hepatology： Vedolizumab浓度，抗药物抗体和α4β7基因与炎症性肠病患者反应的关系, objectType=article, longId=139401, objectId=508513940142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508513940142, replyNumber=0, likeNumber=61, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508513940142, moduleTitle=Clin Gastroenterlogy and Hepatology： Vedolizumab浓度，抗药物抗体和α4β7基因与炎症性肠病患者反应的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508513940142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427122, encodeId=90dc142e1224c, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterlogy and Hepatology：食管粘膜阻抗模式对GERD患者嗜酸细胞性食管炎患者的鉴别诊断有很大价值, objectType=article, longId=139400, objectId=66df139400d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66df139400d1, replyNumber=0, likeNumber=68, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66df139400d1, moduleTitle=Clin Gastroenterlogy and Hepatology：食管粘膜阻抗模式对GERD患者嗜酸细胞性食管炎患者的鉴别诊断有很大价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66df139400d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427121, encodeId=fed5142e12193, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterlogy and Hepatology：超范围夹在治疗高危胃肠道出血中有很好的疗效, objectType=article, longId=139399, objectId=21fb139399b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21fb139399b2, replyNumber=0, likeNumber=63, createdTime=2018-05-31, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21fb139399b2, moduleTitle=Clin Gastroenterlogy and Hepatology：超范围夹在治疗高危胃肠道出血中有很好的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21fb139399b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427120, encodeId=22a4142e1206e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：在意大利口服直接抗病毒治疗时代之前，丙型肝炎病毒相关慢性肝病患者的特点, objectType=article, longId=139296, objectId=a7b7139296b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7b7139296b0, replyNumber=0, likeNumber=52, createdTime=2018-05-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7b7139296b0, moduleTitle=Eur J Gastroenterol Hepatol：在意大利口服直接抗病毒治疗时代之前，丙型肝炎病毒相关慢性肝病患者的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7b7139296b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427119, encodeId=b5fc142e119da, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：DAA治疗前后，肝硬度和肝脂肪变性的变化, objectType=article, longId=139290, objectId=25d713929092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d713929092, replyNumber=0, likeNumber=61, createdTime=2018-05-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d713929092, moduleTitle=Eur J Gastroenterol Hepatol：DAA治疗前后，肝硬度和肝脂肪变性的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d713929092)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427118, encodeId=a7dc142e118cc, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：严重的肝功能衰竭而非肝硬化与感染性心内膜炎患者的死亡率有关, objectType=article, longId=139287, objectId=57f813928e70, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f813928e70, replyNumber=0, likeNumber=76, createdTime=2018-05-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f813928e70, moduleTitle=Eur J Gastroenterol Hepatol：严重的肝功能衰竭而非肝硬化与感染性心内膜炎患者的死亡率有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f813928e70)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427117, encodeId=81b8142e1179e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Eur J Gastroenterol Hepatol：荟萃分析中结果表明，NAFLD患者患白蛋白尿的风险显著增加, objectType=article, longId=139282, objectId=3f521392821b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f521392821b, replyNumber=0, likeNumber=71, createdTime=2018-05-29, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f521392821b, moduleTitle=Eur J Gastroenterol Hepatol：荟萃分析中结果表明，NAFLD患者患白蛋白尿的风险显著增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f521392821b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427116, encodeId=29f8142e116b5, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroen Hepatol：Elobixibat治疗慢性便秘效果显著, objectType=article, longId=139103, objectId=fdd013910344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdd013910344, replyNumber=0, likeNumber=168, createdTime=2018-05-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdd013910344, moduleTitle=Lancet Gastroen Hepatol：Elobixibat治疗慢性便秘效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdd013910344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427115, encodeId=4183142e115e9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology:这一方案成功使3岁慢乙肝患儿获临床治愈, objectType=article, longId=138994, objectId=e15e13899435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e15e13899435, replyNumber=0, likeNumber=78, createdTime=2018-05-25, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e15e13899435, moduleTitle=Hepatology:这一方案成功使3岁慢乙肝患儿获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e15e13899435)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EPA

2020-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差

2018-06-07

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Viral Hepat：埃及丙型肝炎患者采用DAA治疗后，肝癌复发率增加

2018-06-07

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatol Res：在日本CHB患者中，早期从恩替卡韦治疗转换到聚乙二醇干扰素的序贯治疗，结果并不令人满意

2018-06-06

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：慢加急性肝功能衰竭(ACLF)和失代偿性肝硬化(INR)患者凝血功能衰竭

2018-06-06

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：肝硬化和患者的一般状况对肝内胆管癌的影响

2018-06-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatol Res：肝硬化患者脾脏组织的病理结果

2018-06-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatol Res：在韩国接受恩替卡韦/替诺福韦治疗的慢性乙型肝炎患者的肝细胞癌风险

2018-06-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：患有非酒精性肝病的糖尿病患者，其心血管疾病的风险增加

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：HA和M30，联合或单独使用，可能能够预测非酒精性肝病患者的显著肝纤维化

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：一种新的非侵入性测试用于非酒精性脂肪性肝炎的诊断

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：先前的乙型肝炎病毒感染可能加重了原发性胆汁性胆管炎的严重程度，可能导致较差的结果

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterlogy and Hepatology： Vedolizumab浓度，抗药物抗体和α4β7基因与炎症性肠病患者反应的关系

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterlogy and Hepatology：食管粘膜阻抗模式对GERD患者嗜酸细胞性食管炎患者的鉴别诊断有很大价值

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterlogy and Hepatology：超范围夹在治疗高危胃肠道出血中有很好的疗效

2018-05-31

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：在意大利口服直接抗病毒治疗时代之前，丙型肝炎病毒相关慢性肝病患者的特点

2018-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：DAA治疗前后，肝硬度和肝脂肪变性的变化

2018-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：严重的肝功能衰竭而非肝硬化与感染性心内膜炎患者的死亡率有关

2018-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Eur J Gastroenterol Hepatol：荟萃分析中结果表明，NAFLD患者患白蛋白尿的风险显著增加

2018-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroen Hepatol：Elobixibat治疗慢性便秘效果显著

2018-05-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology:这一方案成功使3岁慢乙肝患儿获临床治愈

2018-05-25

科室
- - 订阅+
  - 更多科室
工具
服务